BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11873793)

  • 1. Sharing of profits is debated as the value of tissue rises.
    Kolata G
    N Y Times Web; 2000 May; ():A1,7. PubMed ID: 11873793
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospecting for genetic gold: compensating genetic research donors.
    Triber GA
    J Biolaw Bus; 1998; 2(1):20-8. PubMed ID: 11657635
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA banking and informed consent -- part 1.
    Weir RF; Horton JR
    IRB; 1995; 17(4):1-4. PubMed ID: 11654216
    [No Abstract]   [Full Text] [Related]  

  • 4. Profiting from patient tissue: can patients lay claim to profits from products derived from their tissues?
    Med World News; 1985 Jun; 26(11):63. PubMed ID: 11645555
    [No Abstract]   [Full Text] [Related]  

  • 5. Research that could yield marketable products from human materials: the problem of informed consent.
    Levine RJ
    IRB; 1986; 8(1):6-7. PubMed ID: 11649703
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene treaty promises rewards for unique peoples.
    Coghlan A
    New Sci; 1996 Nov; 152(2054):8. PubMed ID: 11656591
    [No Abstract]   [Full Text] [Related]  

  • 7. Proprietary rights in body parts: the relevance of Moore's case in Australia.
    Mortimer D
    Monash Univ Law Rev; 1993; 19(1):217-25. PubMed ID: 17333577
    [No Abstract]   [Full Text] [Related]  

  • 8. India fears patent and ethics abuses.
    Schüklenk U
    Nat Biotechnol; 1997 Jul; 15(7):613. PubMed ID: 11644986
    [No Abstract]   [Full Text] [Related]  

  • 9. Informed consent: defining limits through therapeutic parameters.
    Daar JF
    Whittier Law Rev; 1995; 16(1):187-209. PubMed ID: 11660487
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA banking and informed consent -- part 2.
    Weir RF; Horton JR
    IRB; 1995; 17(5-6):1-8. PubMed ID: 11653356
    [No Abstract]   [Full Text] [Related]  

  • 11. Moore v. Regents of the University of California: expanded disclosure, limited property rights.
    Potts J
    Northwest Univ Law Rev; 1992; 86(2):453-96. PubMed ID: 11659500
    [No Abstract]   [Full Text] [Related]  

  • 12. Homo economicus: commercialization of body tissue in the age of biotechnology.
    Nelkin D; Andrews L
    Hastings Cent Rep; 1998; 28(5):30-9. PubMed ID: 11656768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation in pedigree studies and the risk of impeded access to health insurance.
    Kass NE
    IRB; 1993; 15(5):7-10. PubMed ID: 11659704
    [No Abstract]   [Full Text] [Related]  

  • 14. Ruling renews fears of limits on research.
    Reinhold R
    N Y Times Web; 1988 Jul; ():19. PubMed ID: 11646695
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue banking: genetic donations and informed consent.
    Swibel LH
    Princet J Bioeth; 1999; 2(1):6-17. PubMed ID: 11658144
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene donors' rights at risk.
    Nature; 1996 May; 381(6577):1. PubMed ID: 8609968
    [No Abstract]   [Full Text] [Related]  

  • 17. Moore v. Regents of the University of California: patients, property rights, and public policy.
    Biagi KG
    St Louis Univ Law J; 1991; 35(2):433-62. PubMed ID: 16144099
    [No Abstract]   [Full Text] [Related]  

  • 18. Source compensation for tissues and cells used in biotechnical research: why a source shouldn't share in the profits.
    Dillon TP
    Notre Dame Law Rev; 1989; 64(4):628-45. PubMed ID: 11650898
    [No Abstract]   [Full Text] [Related]  

  • 19. Human tissue research: who owns the results?
    Wagner AB
    J Pat Trademark Off Soc; 1987 Jun; 69(6):329-52. PubMed ID: 11649984
    [No Abstract]   [Full Text] [Related]  

  • 20. Religious leaders prepare to fight patents on genes.
    Andrews EL
    N Y Times Web; 1995 May; ():1, 35. PubMed ID: 11647071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.